Abstract
To evaluate two different regimens for gentamicin administration (once or twice daily) in newborns with suspected sepsis, and the ability of these regimens to achieve recommended serum gentamicin concentrations (SGC) within the therapeutic range. Setting Neonatal intensive care unit. We conducted a retrospective study of newborns > or =34 weeks gestational age (GA) admitted with suspected sepsis to the neonatal unit at Stavanger University Hospital from 1st February 2003 to 31st May 2005. During the first period patients received gentamicin 2.5 mg/kg twice daily (n = 62) and during the last period patients received gentamicin 4 mg/kg once daily (n = 73). In both groups, levels of gentamicin were obtained before and after the third given dose. Mean peak levels were lower and mean trough levels were higher in the twice daily regimen compared to the once daily regimen (P < 0.001 for both). About 16 newborns in the twice daily regimen had trough levels higher than the recommended level (<2 microg/ml) compared to two children in the once daily regimen (P < 0.001). High peak levels (>10 microg/ml) were achieved in one child in the twice daily regimen compared to eight children in the once daily regimen (P = 0.04). The number of children with a low peak level (<5 microg/ml) was only three and one respectively (n.s). In newborns with suspected sepsis, gentamicin 4 mg/kg once daily provided higher peak and lower trough gentamicin levels compared to administering gentamicin 2.5 mg twice daily.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.